Journal Information
Vol. 16. Issue 4.
Pages 559-572 (July - August 2010)
Share
Share
Download PDF
More article options
Vol. 16. Issue 4.
Pages 559-572 (July - August 2010)
Artigo de Revisão/Review Article
Open Access
Abordagem terapêutica da tuberculose e resolução de alguns problemas associados à medicação
Tuberculosis treatment and management of some problems related to the medication
Visits
8348
R. Duarte1,2,3,4,
,**
Corresponding author
raquelafduarte@gmail.com

Correspondência/Correspondence to: Raquel Duarte, CDP de Vila Nova de Gaia, Rua Conselheiro Veloso, Vila Nova de Gaia
, A. Carvalho1,2,*, D. Ferreira1,*, S. Saleiro5,*, R. Lima1,*, M. Mota1,*, E. Raymundo6,*, M. Villar7,8,*, A. Correia9,*
1 Centro Hospitalar de Vila Nova de Gaia/Espinho
2 Centro Diagnóstico Pneumológico de Vila Nova de Gaia
3 Faculdade de Medicina da Universidade do Porto
4 Centro de Referência para a TBMR da Região Norte
5 Serviço de Pneumologia. Hospital de São João, Porto
6 Centro Diagnóstico Pneumológico de Vila Franca de Xira
7 Centro Diagnóstico Pneumológico de Venda Nova, Amadora
8 Centro de Referência para a TBMR
9 Departamento de Saúde Pública. Administração Regional do Norte
* Comissão de Trabalho de Tuberculose da Sociedade Portuguesa de Pneumologia
Ver más
This item has received

Under a Creative Commons license
Article information
Resumo

A tuberculose é uma doença bem conhecida e para a qual há fármacos de reconhecida eficácia. Em Portugal, a incidência da tuberculose tem vindo a diminuir de forma consistente nos últimos anos, mantendo contudo valores acima da média europeia. Uma nova dificuldade surge, associada à resistência aos antibacilares reconhecidamente relacionada com a não adesão ao tratamento e/ou a uma incorrecta escolha do regime terapêutico. Assim, é importante focar a atenção na abordagem inicial do caso de tuberculose, sendo esse o objectivo desta revisão.

Rev Port Pneumol 2010; XVI (4): 559-572

Palavras-chave:
Tuberculose
tratamento
efeitos colaterais
Abstract

Tuberculosis is a well-known illness for which there is treatment of recognized effectiveness. In Portugal, tuberculosis incidence has been diminishing although keeping values higher than the rest of the Western Europe. A new challenge is associated with resistance to drugs, admittedly related to treatment noncompliance or incorrect treatment choice. The purpose of this review to focus our attention on the importante of the first approach to the tuberculosis case.

Rev Port Pneumol 2010; XVI (4): 559-572

Key-words:
Tuberculosis
treatment
side effects
Full text is only aviable in PDF
Bibliografia
[1.]
DGS. Programa Nacional de Luta Contra a Tuberculose.
[2.]
D.A. Mitchinson, A.J. Nunn.
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
Am Rev Resp Dis, 133 (1986), pp. 430-433
[3.]
CDC – National Center for HIV/AIDS, viral hepatitis, STD and TB prevention.
Core curriculum on tuberculosis.
[4.]
New York City Department of Health and Mental Higyene.
Tuberculosis – Clinical policies and protocols, 4th edition, (2008),
[5.]
American Thoracic Society Documents.
American Thoracic Society / Centers of Disease Control and Prevention / Infectious Diseases Society of America: treatment of tuberculosis.
Am J Respir Crit Care Med, 167 (2003), pp. 603-662
[6.]
R.E. Chaisson, H.C. Clermont, E.A. Holt, H.C. Clermont, M. Holt EA, M.P. Johnson, J. Atkinson, H. Davis, R. Boulos, et al.
JHU-CDS Research Team. Six-months supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection.
Am J Respir Crit Care Med, 154 (1996), pp. 1034-1038
[7.]
T.R. Sterling, K. Alwood, R. Gachuhi, et al.
Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
AIDS, 13 (1999), pp. 1899-1904
[8.]
W.M. El-Sadr, D.C. Perlman, E. Denning, J.P. Matts, D.L. Cohn.
A review of efficacy studies of 6-month shortcourse therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.
Clin Infect Dis, 32 (2001), pp. 623-632
[9.]
J. Murray, P. Sonnenberg, S.C. Shearer, P. Godfrey Fausett.
Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.
Am J Respir Crit Care Med, 159 (1999), pp. 733
[10.]
T.B. Stop, Partnership Childhood TB Subgroup, World Health Organization.
Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 2: anti-tuberculosis treatment in children.
Int J Tuberc Lung Dis, 10 (2006), pp. 1205-1211
[11.]
Grupo de Trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica (SEIP).
Treatment of extrapulmonary tuberculosis and complicated forms of pulmonary tuberculosis.
An Pediatr, 69 (2008), pp. 271-278
[12.]
American Thoracic Society Documents.
American Thoracic Society/Centers for Disease Control and Pre-vention/Infectious Diseases Society of America: treatment of tuberculosis.
Am J Respir Crit Care Med, 167 (2003), pp. 603-662
[13.]
N.R. Budha, R.E. Lee, B. Meibohm.
Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs.
Curr Med Chem, 15 (2008), pp. 809-825
[14.]
Bothamley G. Drug treatment for tuberculosis during pregnancy: Safety considerations. Drug Safety 24(7):553-565.
[15.]
World Health Organization.
Treatment of tuberculosis: guidelines for national programmes, 2nd edition, (1997),
[16.]
World Health Organization.
Guidelines for the programmatic management of drug-resistant tuberculosis.
[17.]
R. Zaleskis, WHO Regional Office for Europe. Postgraduate Course ERS Copenhagen.
The side effects of TB therapy.
[18.]
Direcção-Geral de Saúde. Circular Normativa n.º 19/DSCS/PNT de 17/10/2007 a 2007-10-17. Assunto: Rastreio de infecção VIH nos doentes com tuberculose. Acessível em: http://www.dgs.pt/.
[19.]
L.L. Flores, M. Pai, J.M. Colford Jr., L.W. Riley.
In–house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: metaanalysis and meta-regression.
BMC Microbiol, 5 (2005), pp. 55
[20.]
F. Antunes, M. Villar, R. Duarte, U. Brito, A. Abreu, et al.
Tuberculose multirresistente.
Orientações técnicas para o controlo, prevenção e vigilância em Portugal,
Copyright © 2010. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?